Stocks and Investing
Stocks and Investing
Tue, October 18, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Charlie Chan Downgraded (ACMR) to Hold and Decreased Target to $9 on, Oct 18th, 2022
Charlie Chan of Morgan Stanley, Downgraded "ACM Research, Inc." (ACMR) to Hold and Decreased Target from $28 to $9 on, Oct 18th, 2022.
Charlie has made no other calls on ACMR in the last 4 months.
There is 1 other peer that has a rating on ACMR. Out of the 1 peers that are also analyzing ACMR, 0 agree with Charlie's Rating of Hold.
This is the rating of the analyst that currently disagrees with Charlie
- Nick Cheng of "Jefferies" Downgraded from Strong Buy to Sell and Decreased Target to $8 on, Tuesday, October 11th, 2022
Contributing Sources